Abstract:Inserting custom designed DNA sequences into the mammalian genome plays an essential role in synthetic biology. In particular, the ability to introduce foreign DNA in a site-specific manner offers numerous advantages over random DNA integration. In this review, we focus on two mechanistically distinct systems that have been widely adopted for targeted DNA insertion in mammalian cells, the CRISPR/Cas9 system and site-specific recombinases. The CRISPR/Cas9 system has revolutionized the genome engineering field thanks to its high programmability and ease of use. However, due to its dependence on linearized DNA donor and endogenous cellular pathways to repair the induced double-strand break, CRISPR/Cas9-mediated DNA insertion still faces limitations such as small insert size, and undesired editing outcomes <i>via</i> error-prone repair pathways. In contrast, site-specific recombinases, in particular the Serine integrases, demonstrate large-cargo capability and no dependence on cellular repair pathways for DNA integration. Here we first describe recent advances in improving the overall efficacy of CRISPR/Cas9-based methods for DNA insertion. Moreover, we highlight the advantages of site-specific recombinases over CRISPR/Cas9 in the context of targeted DNA integration, with a special focus on the recent development of programmable recombinases. We conclude by discussing the importance of protein engineering to further expand the current toolkit for targeted DNA insertion in mammalian cells.This article has not yet been cited by other publications.

Recent advances in targeted genome engineering in mammalian systems.

[Applications of ZFN, TALEN and CRISPR/Cas9 Techniques in Disease Modeling and Gene Therapy].

Various applications of TALEN- and CRISPR/Cas9-mediated homologous recombination to modify the Drosophila genome.

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Application of Zinc Finger Nucleases in Genome Targeting Modification

A history of genome editing in mammals

Expanding the Potential of Mammalian Genome Engineering via Targeted DNA Integration

[Advances in Genetic Modification Technologies].

Progress in zinc finger nuclease engineering for targeted genome modification]

Genome-Editing Technologies: Principles and Applications.

Progress of New-Generation Genome Editing Mediated by Engineered Endonucleases

Applications of Genome Editing Technology in the Targeted Therapy of Human Diseases:Mechanisms,advances and Prospects

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

[TALE Nuclease Engineering and Targeted Genome Modification].

Genome engineering using the CRISPR-Cas9 system

Generating a Genome Editing Nuclease for Targeted Mutagenesis in Human Cells.

To Cut or Not to Cut: Next-generation Genome Editors for Precision Genome Engineering

Genome Targeting Modification Technology Based on TALE Nuclease Engineering

Gene targeting in the mouse: advances in introduction of transgenes into the genome by homologous recombination

[Recent Developments in Enhancing the Efficiency of CRISPR/Cas9- Mediated Knock-in in Animals].